EMR Versus CSP in the Treatment of Sessile Serrated Lesions Less Than 10mm in Size

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-75
SponsorFudan University

About this trial

A prospective, single-center, open-label, randomized controlled study to compare the effectiveness and safety of endoscopic mucosal resection (EMR) and cold snare polypectomy (CSP) in treating colorectal sessile serrated lesions (SSLs) less than 10mm in size.

Eligibility criteria

Qualifiers

Aged between 35 and 75 years

Suspected sessile serrated lesions less than 10mm in size in screening, surveillance or therapeutic colonoscopy

0-Is or 0-IIa according to Paris classification

Type 1 according to NICE and JNET classification

Disqualifiers

Unsuitable for removal by EMR or CSP

Suspected dysplasia or malignancy

Recurrent sessile serrated lesions after endoscopic resection

Familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome

Trial design

Treatments tested in this trial

  • endoscopic mucosal resection
  • Cold snare polypectomy

Treatment groups

270 Participants
are divided into 2 treatment groups

Sponsors and collaborators